Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

INM

InMed Pharmaceuticals Inc.

Healthcare · USD

Set alert

Price alert · INM

All alert types
1.60 USD -0.02 -1.54%
As of Oct 30, 2026 Extended hours 1.51 -5.63%
Bid
1.53 × 10
Ask
1.62 × 2
1.51 Day range 1.61
0.615 52-week range 1.88
YTD
+50.94%
1 year
-13.51%
Open
1.55
Prev close
1.63
Mkt cap
8.79M
Vol
36.68K
Avg vol
70.15K
EPS
-2.84
P/E
0.00
Div yield
0.00%
More statistics
Low
1.51
High
1.61
Forward P/E
-0.75
Beta
0.71
Short ratio
0.12
Inst. own
0.00%
Dividend
0.00
Ex-div date
Earnings
Feb 11, 2025
50-d avg
4.94
200-d avg
5.37
1y target
0.00

5D chart

Chart tools
Interval
1m5m15m30m
INM five-day price chart1.321.411.501.591.68Oct 22Oct 23Oct 26Oct 27Oct 28

Financial health

Altman Z-Score

612.29 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -0.5×
FY 2017: -6.8×FY 2018: -12.1×FY 2019: -4.4×FY 2020: -3.6×FY 2021: -1.7×FY 2022: -0.0×FY 2023: -0.3×FY 2024: -0.2×FY 2025: -0.4×FY 2026: -0.5×
FY 2017 5y median -0.3× FY 2026
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.2×FY 2023: 0.5×FY 2024: 0.4×FY 2025: 0.6×FY 2026: 0.0×
FY 2017 5y median 0.4× FY 2026
P/B 6.0×
FY 2017: 5.2×FY 2018: 5.2×FY 2019: 4.1×FY 2020: 7.4×FY 2021: 2.3×FY 2022: 0.0×FY 2023: 0.1×FY 2024: 0.2×FY 2025: 0.2×FY 2026: 6.0×
FY 2017 5y median 0.2× FY 2026
P/FCF -0.0×
FY 2017: -13.5×FY 2018: -28.9×FY 2019: -8.6×FY 2020: -5.9×FY 2021: -2.2×FY 2022: -0.0×FY 2023: -0.3×FY 2024: -0.3×FY 2025: -0.4×FY 2026: -0.0×
FY 2017 5y median -0.3× FY 2026
EV/EBITDA -0.5×
FY 2017: -8.0×FY 2018: -10.1×FY 2019: -4.6×FY 2020: -4.4×FY 2021: -1.0×FY 2022: 0.4×FY 2023: 1.2×FY 2024: 0.8×FY 2025: 1.5×FY 2026: -0.5×
FY 2017 5y median 0.8× FY 2026
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -6.1×FY 2023: -2.2×FY 2024: -1.3×FY 2025: -2.2×FY 2026: 0.0×
FY 2017 5y median -2.2× FY 2026
FCF Yield -133933.7%
FY 2017: -7.4%FY 2018: -3.5%FY 2019: -11.7%FY 2020: -17.0%FY 2021: -45.8%FY 2022: -5930.4%FY 2023: -328.0%FY 2024: -365.0%FY 2025: -244.9%FY 2026: -133933.7%
FY 2017 5y median -365.0% FY 2026

Profitability

Gross Margin 22.3%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 49.9%FY 2023: 33.9%FY 2024: 23.9%FY 2025: 34.5%FY 2026: 22.3%
FY 2017 5y median 33.9% FY 2026
Operating Margin -0.3%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -1266.0%FY 2023: -202.6%FY 2024: -176.9%FY 2025: -160.2%FY 2026: -0.3%
FY 2017 5y median -176.9% FY 2026
Net Margin -0.4%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -1707.3%FY 2023: -192.2%FY 2024: -166.9%FY 2025: -165.1%FY 2026: -0.4%
FY 2017 5y median -166.9% FY 2026
ROE -1168.4%
FY 2017: -56.2%FY 2018: -43.1%FY 2019: -72.1%FY 2020: -152.1%FY 2021: -138.7%FY 2022: -159.1%FY 2023: -49.6%FY 2024: -61.0%FY 2025: -44.6%FY 2026: -1168.4%
FY 2017 5y median -61.0% FY 2026
ROIC -920.5%
FY 2017: -71.4%FY 2018: -43.5%FY 2019: -97.4%FY 2020: -147.7%FY 2021: -128.7%FY 2022: -108.5%FY 2023: -50.7%FY 2024: -58.5%FY 2025: -41.0%FY 2026: -920.5%
FY 2017 5y median -58.5% FY 2026
ROA -414.5%
FY 2017: -53.7%FY 2018: -41.6%FY 2019: -66.4%FY 2020: -114.6%FY 2021: -104.6%FY 2022: -113.0%FY 2023: -42.5%FY 2024: -47.5%FY 2025: -38.5%FY 2026: -414.5%
FY 2017 5y median -47.5% FY 2026

Growth (YoY)

Revenue 64167.3%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 279.6%FY 2024: 11.2%FY 2025: 7.5%FY 2026: 64167.3%
FY 2017 FY 2026
Operating Income -25.0%
FY 2017: -88.7%FY 2018: -105.2%FY 2019: -50.6%FY 2020: 32.3%FY 2021: -33.0%FY 2022: -13.3%FY 2023: 39.2%FY 2024: 2.9%FY 2025: 2.7%FY 2026: -25.0%
FY 2017 FY 2026
EPS (diluted) 62.7%
FY 2017: -25.9%FY 2018: -27.3%FY 2019: -22.6%FY 2020: 8.2%FY 2021: 19.1%FY 2022: -1666.1%FY 2023: 99.6%FY 2024: 69.0%FY 2025: 58.5%FY 2026: 62.7%
FY 2017 FY 2026
Free Cash Flow -111185.8%
FY 2017: -516.3%FY 2018: -56.1%FY 2019: -80.2%FY 2020: -10.6%FY 2021: -32.0%FY 2022: -59.5%FY 2023: 52.3%FY 2024: 6.0%FY 2025: -11.0%FY 2026: -111185.8%
FY 2017 FY 2026

Financial Health

Current Ratio 1.4×
FY 2017: 18.8×FY 2018: 28.5×FY 2019: 11.9×FY 2020: 3.8×FY 2021: 3.8×FY 2022: 2.9×FY 2023: 5.7×FY 2024: 4.4×FY 2025: 7.0×FY 2026: 1.4×
FY 2017 5y median 4.4× FY 2026
Quick Ratio 1.4×
FY 2017: 18.8×FY 2018: 28.5×FY 2019: 11.9×FY 2020: 3.8×FY 2021: 3.8×FY 2022: 2.1×FY 2023: 4.9×FY 2024: 3.8×FY 2025: 6.5×FY 2026: 1.4×
FY 2017 5y median 3.8× FY 2026
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.1×FY 2025: 0.1×FY 2026: 0.0×
FY 2017 5y median 0.1× FY 2026
Net Debt / EBITDA 0.2×
FY 2017: 1.5×FY 2018: 2.1×FY 2019: 1.0×FY 2020: 0.6×FY 2021: 0.7×FY 2022: 0.4×FY 2023: 1.5×FY 2024: 1.1×FY 2025: 1.9×FY 2026: 0.2×
FY 2017 5y median 1.1× FY 2026
Interest Coverage -925×
FY 2017: -8837×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -492×FY 2021: -33.8×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -21.2×FY 2026: -925×
FY 2017 5y median 0.0× FY 2026

Dividends

Dividend Yield 6688.8%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 6688.8%
FY 2017 5y median 0.0% FY 2026
Payout Ratio -3436.6%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: -3436.6%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-06-30